|
ACC 2019?
|
3
|
Resverlogix Corp.
|
Nov 19, 2018 04:45PM
|
|
Re: If this trial were made up of ONLY placebo patients,..
|
3
|
Resverlogix Corp.
|
Nov 19, 2018 02:44PM
|
|
Re: Primary endpoint: Time vs Absolute Numbers
|
6
|
Resverlogix Corp.
|
Nov 19, 2018 12:27PM
|
|
Re: Why such little intrest, so close to the finis
|
2
|
Resverlogix Corp.
|
Nov 19, 2018 11:49AM
|
|
Re: Why such little intrest, so close to the finis
|
3
|
Resverlogix Corp.
|
Nov 16, 2018 09:18PM
|
|
Re: Why such little intrest, so close to the finis
|
4
|
Resverlogix Corp.
|
Nov 16, 2018 04:38PM
|
|
NEJM Editorial on REDUCE-IT
|
3
|
Resverlogix Corp.
|
Nov 16, 2018 12:29PM
|
|
Re: Inverted Hammer
|
4
|
Resverlogix Corp.
|
Nov 15, 2018 01:04PM
|
|
Re: Inverted Hammer
|
4
|
Resverlogix Corp.
|
Nov 14, 2018 11:51AM
|
|
Re: AHA 2018 Resverlogix Poster #2
|
4
|
Resverlogix Corp.
|
Nov 13, 2018 09:51AM
|
|
Re: apabetalone and colorectal cancer
|
1
|
Resverlogix Corp.
|
Nov 13, 2018 09:40AM
|
|
Re: AHA 2018 Resverlogix Poster #1
|
3
|
Resverlogix Corp.
|
Nov 12, 2018 10:46PM
|
|
Re: AHA 2018
|
2
|
Resverlogix Corp.
|
Nov 12, 2018 08:48PM
|
|
AHA 2018 Resverlogix Poster #2
|
4
|
Resverlogix Corp.
|
Nov 12, 2018 05:43PM
|
|
Re: AHA 2018 Resverlogix Poster #1
|
5
|
Resverlogix Corp.
|
Nov 12, 2018 05:01PM
|
|
Re: Amarin CEO interview
|
6
|
Resverlogix Corp.
|
Nov 12, 2018 03:02PM
|
|
Re: AHA 2018
|
5
|
Resverlogix Corp.
|
Nov 11, 2018 09:56PM
|
|
AHA 2018 Resverlogix Poster #1
|
5
|
Resverlogix Corp.
|
Nov 11, 2018 03:17PM
|
|
Re: BIO-Europe tomorrow
|
3
|
Resverlogix Corp.
|
Nov 11, 2018 03:12PM
|
|
Re: AHA 2018
|
1
|
Resverlogix Corp.
|
Nov 11, 2018 10:17AM
|
